New Delhi: Recently the Indian Council of Medical Research (ICMR) had said that the corona virus vaccine would be launched in India by 15 August, on which many experts had expressed concern about this deadline. In this regard, the ICMR has clarified on Saturday that the vaccine process will be based on global standards. The Indian company Bharat Biotech and ICMR are working together on this vaccine.
Furthermore, the medical body said that its process is exactly in accordance with globally accepted norms to fast-track the vaccine development for diseases of pandemic potential wherein human and animal trials can continue in parallel.
“Just as red tape was not allowed to become a hindrance in the fast-track approval of new indigenous testing kits or for introducing in the Indian market potential COVID-19 related drugs, the indigenous vaccine development process has also been sought to be insulated from slow file movement,” the statement issued by the ICMR read.
It is expected that India’s first indigenous COVID-19 vaccine, Covaxin may be released on August 15 under a fast-track mechanism. According to the government’s top medical research body, a dozen institutes have been selected for clinical trials of the indigenous COVID-19 vaccine (BBV152 COVID vaccine).
